We have moved to new location, Please click on contact us  
Home  >  News
you can get e-magazine links on WhatsApp. Click here
  Intra-Cellular reports positive results from Study 403 evaluating lumateperone as monotherapy in patients with MDD with mixed features and bipolar depression with mixed features,   March 30, 2023
  Viking Therapeutics begins phase 1 study to evaluate oral formulation of dual GLP-1/GIP receptor agonist, VK2735,   March 29, 2023
  Merck announces Keytruda plus chemotherapy significantly improved PFS compared to chemotherapy alone for advanced or recurrent endometrial carcinoma, regardless of mismatch repair status,   March 29, 2023
  GSK announces phase III RUBY trial demonstrates potential of Jemperli plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone,   March 29, 2023
  Baudax Bio reports positive results from 2nd interim analysis of phase 2 randomized trial for BX1000,   March 28, 2023
  NRx Pharma gets DSMB positive recommendation to continue enrollment in ongoing trial of NRX-101 in patients with suicidal treatment-resistant bipolar depression,   March 28, 2023
  Novartis Kisqali phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in broad population of patients with early breast cancer,   March 28, 2023
  Eplontersen demonstrated sustained benefit in phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy through 66 weeks,   March 28, 2023
  Neurelis begins patient dosing in investigational study of ROCK inhibitor, NRL-1049 to treat cerebral cavernous malformations,   March 27, 2023
  US FDA issues draft guidance aimed at improving oncology clinical trials for accelerated approval,   March 27, 2023
  Bayer expands global clinical programme for darolutamide in prostate cancer,   March 25, 2023
  Transcenta doses first patient in US phase 1 study of Gremlin1 targeting antibody TST003 to treat solid tumours,   March 24, 2023
  Dupixent demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial,   March 24, 2023
  Disc Medicine collaborates with NIH for phase 2 study of bitopertin in patients with Diamond-Blackfan anaemia,   March 23, 2023
  Astellas presents positive results from phase 3 GLOW trial of zolbetuximab plus Capox during March ASCO plenary series,   March 23, 2023
  Jacobio enters clinical collaboration with Merck to evaluate CD73 monoclonal antibody JAB-BX102 in combo with Keytruda for patients with cancer,   March 23, 2023
  UK MHRA to streamline clinical trial approvals in biggest overhaul of trial regulation in 20 years,   March 23, 2023
  New data show remote monitoring technology like Abbott’s CardioMEMS HF System helps improve survival in heart failure patients,   March 23, 2023
  Sensei Biotherapeutics submits IND application to US FDA for phase 1/2 trial of SNS-101 to treat patients with solid tumours,   March 22, 2023
  Phanes Therapeutics initiates patient dosing in phase 1 study of PT886 for advanced gastric, gastroesophageal junction and pancreatic adenocarcinomas,   March 22, 2023

India Lab Expo
Copyright © 2016 Saffron Media Pvt. Ltd |